During their recent episode, Taylor, Carlisle, and Jonathan Tepper discussed:Building a Dominant Long-Only Fund in a Distorted MarketBuying Booking at Peak Fear: COVID, Google & Mispriced RiskWill AI Disintermediate the Platforms?AI Winners, Losers & the SaaS ApocalypseThe Myth of Capitalism: Why Profit Margins Stay HighHas the Antitrust Pendulum Swung Back?Shooting Up: A Childhood Inside Spain’s Heroin CrisisThe Five Rungs of Intelligence — and the Investor’s LadderYou can find out more about the VALUE: Af ...

Core Insights - Steven Conine, Co-Founder of Wayfair, sold 26,950 shares for approximately $2.13 million, indicating a significant transaction in the context of his overall ownership [1][2]. Company Overview - Wayfair is a global online retailer specializing in home goods, with a revenue of $12.46 billion and a net loss of $313 million over the trailing twelve months (TTM) [4][5]. - The company employs 12,800 people and has experienced a 79.09% price change over the past year as of February 28, 2026 [4]. Financial Performance - Wayfair's stock increased by approximately 120% in 2025, but it is currently down about 28% in 2026 [6][8]. - The company has reported two consecutive quarters of net losses, raising concerns about its planned expansion amidst a challenging market [7][9]. Market Challenges - Wayfair faces challenges from tariffs that are increasing material costs, despite the Supreme Court's recent decision to strike down some tariffs [6]. - The home furnishing retail sector has been significantly impacted by inflation, leading to skepticism regarding the company's expansion plans in a less favorable market [7]. Transaction Analysis - The recent sale of shares by Conine reduced his direct holdings by 12.31%, leaving him with 169,073 shares directly and 22,857 shares indirectly [2][8]. - The number of shares sold is below Conine's recent median sell transaction of 85,000 shares, based on 19 transactions since May 2025 [8].

Core Viewpoint - Sabre Corporation has adopted a limited-duration shareholder rights plan to protect its interests and those of its shareholders in response to significant stock accumulation by Constellation Software Inc [1] Group 1: Shareholder Rights Plan - The Rights Plan is effective immediately and will expire in one year, specifically on February 28, 2027 [1] - The plan was adopted after observing unusually high trading volumes in Sabre's stock during the week of February 23 to February 27, 2026 [1] - Constellation Software accumulated a 9.7% economic position in Sabre between April 2025 and November 2025, which includes 4.7% beneficial ownership and 5% via derivative instruments [1] Group 2: Board's Considerations - The Board attempted to reengage with Constellation on February 26 and 27, 2026, but received no response, and Constellation withdrew a nomination for a second candidate on February 28, 2026 [1] - Constellation had previously expressed a desire for its investment in Sabre to mirror its 24.8% position in Asseco Poland S.A. [1] - The Board remains open to resuming discussions with Constellation regarding a negotiated agreement on acceptable terms [1] Group 3: Rights Plan Details - Under the Rights Plan, one right will be issued for each share of common stock as of March 11, 2026, and rights will become exercisable if any person acquires 15% or more of the outstanding common stock [1] - If the rights become exercisable, holders (excluding the triggering person) can acquire shares at a 50% discount or exchange each right for one share of common stock [1] - The Rights Plan does not limit the ability of a future board of directors to redeem the rights and does not aggregate ownership of shareholders acting in concert until they form a group under applicable securities laws [1]

Core Viewpoint - The article emphasizes the importance of a hybrid investment strategy that combines classic dividend growth stocks with Business Development Companies, REITs, and Closed End Funds to enhance investment income while achieving total returns comparable to traditional index funds. Group 1: Investment Strategy - A solid base of classic dividend growth stocks can be complemented with other asset types to create a diversified portfolio [1] - The hybrid system developed allows for capturing total returns that align with the performance of the S&P index [1] Group 2: Investment Focus - The focus is on high-quality dividend stocks and assets that provide potential for long-term growth and income generation [1] - The strategy aims to boost investment income effectively while maintaining a balance between growth and income [1]

Core Insights - Berkshire Hathaway Specialty Insurance (BHSI) has appointed Marcus Portbury as Regional President for Asia Middle East (AME) and Chief Executive of the Hong Kong Branch, pending regulatory approval [1][2] - Marcus Portbury succeeds Marc Breuil, who is retiring after a successful career in the insurance industry [1][2] Company Overview - BHSI provides a comprehensive range of commercial property and casualty insurance, including healthcare professional liability, executive and professional lines, and accident & health insurance [4] - The company holds strong financial ratings, with A++ from AM Best and AA+ from Standard & Poor's, indicating robust financial strength [4] Leadership Transition - Marcus Portbury has been with BHSI since 2014 and has over 30 years of experience in the insurance industry, including more than 20 years in senior leadership roles across Asia [3] - Under Marc Breuil's leadership, BHSI established a strong portfolio and a capable team in the Asia and Middle East regions [2]

Core Insights - Tigo Energy, Inc. has experienced a significant increase in its share price, rising by 294.88% year-over-year [1] Company Overview - Tigo Energy specializes in solar energy solutions and has garnered attention despite limited coverage on platforms like Seeking Alpha [1]

Core Viewpoint - Enphase Energy, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding its financial and operational prospects, particularly related to inventory management and the impact of the expiration of the Residential Clean Energy Credit [1][1]. Summary by Relevant Sections Class Action Lawsuit Details - The class action lawsuit is titled Tripathi v. Enphase Energy, Inc., and it involves investors who purchased Enphase Energy securities between April 22, 2025, and October 28, 2025 [1]. - Investors have until April 20, 2026, to seek appointment as lead plaintiff in the lawsuit [1]. Allegations Against Enphase Energy - The lawsuit alleges that Enphase Energy overstated its ability to manage channel inventory and mitigate the effects of the termination of the Residential Clean Energy Credit [1]. - It is claimed that these misrepresentations led to an overstatement of the company's financial and operational prospects [1]. - On October 28, 2025, Enphase Energy reported financial results indicating that elevated channel inventory would lead to lower battery storage shipments in Q4 2025, and the expiration of the 25D Credit would negatively impact revenues in Q1 2026 [1]. - Following this announcement, Enphase Energy's stock price fell by more than 15% [1]. Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Enphase Energy securities during the class period to seek appointment as lead plaintiff [1]. - The lead plaintiff represents the interests of all class members and can select a law firm to litigate the case [1]. About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [1]. - The firm has a strong track record, recovering $8.4 billion for investors over the past five years [1].

Core Viewpoint - Gunnar Gudlaugsson, Executive Vice President of Global Operations at Century Aluminum, sold 43,000 shares of common stock, marking his largest sale to date, valued at $2.3 million [1][2][5]. Group 1: Transaction Details - The transaction involved the sale of 43,000 shares at a price of $54.10, resulting in a total transaction value of $2.3 million [2]. - Post-transaction, Gudlaugsson holds 136,393 shares, valued at approximately $7.2 million based on the market close price of $53.02 on February 25, 2026 [2]. - This sale is significantly larger than his historical median of 31,500 shares per sale since January 2024 [5]. Group 2: Company Overview - Century Aluminum reported a trailing twelve months (TTM) revenue of $2.53 billion and a net income of $40 million [4]. - The company's stock price increased by 165.91% over the past year as of February 28, 2026 [4]. - The current market capitalization of Century Aluminum is approximately $4.8 billion [5]. Group 3: Industry Context - Century Aluminum is involved in a landmark partnership with Emirates Global Aluminum to establish the first aluminum smoldering plant in the U.S. in 47 years, which is expected to create 1,000 jobs [7]. - The U.S. administration is pushing for increased domestic aluminum production, with tariffs making imports more costly, positioning Century Aluminum to benefit from this trend [8]. - The company's stock surged approximately 150% in 2025 and is up about 31% in 2026, indicating strong demand for aluminum in various consumer and industrial applications [9].

Industry Overview - Artificial intelligence (AI) investing is currently experiencing a lull, with market concerns about the high spending on AI computing and the delayed return on investment [1] - AI leaders emphasize the necessity of significant upfront investment to remain competitive in the tech landscape, despite market skepticism [1] Microsoft - Microsoft (MSFT) is identified as a significant value opportunity during the current market sell-off, having posted strong financial results for Q2 of fiscal year 2026, yet its stock has declined [4] - The stock is down approximately 30% from its all-time high, and its price-to-earnings ratio is at a low not seen since 2020, indicating a potential buying opportunity [5] - Analysts predict a rally in Microsoft's stock, suggesting that now is an opportune time for investors to act [7] Broadcom - Broadcom (AVGO) has also seen a sell-off, with its stock down about 20% since the beginning of 2026, presenting a prime buying opportunity [8] - The company's custom AI chip division is a key growth area, partnering with AI hyperscalers to create specialized chips, which serve as alternatives to expensive GPUs [8] - Analysts project significant revenue growth for Broadcom, with expectations of 53% and 39% revenue growth in fiscal years 2026 and 2027, respectively, indicating potential for revenue to double in two years [9] Nebius - Nebius (NBIS) is a rapidly growing company operating an AI-first cloud computing platform, which is gaining popularity among AI developers [10] - The company had an annual run rate of $1.25 billion at the end of 2025, expected to rise to between $7 billion and $9 billion by the end of 2026, driven by new data centers coming online [11] - Nebius has expanded its operational sites from two in 2024 to seven in 2025, with plans to reach 16 sites by the end of 2026, indicating strong demand for its services [12]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Vistagen Therapeutics, Inc. during the specified Class Period of the upcoming lead plaintiff deadline on March 16, 2026 [1]. Group 1: Class Action Details - Investors who bought Vistagen common stock between April 1, 2024, and December 16, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][7]. - To serve as lead plaintiff, individuals must file a motion with the Court by March 16, 2026, representing other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked among the top firms for securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. Group 3: Case Background - The lawsuit alleges that Vistagen's defendants provided misleading information regarding the development and commercialization of its drug fasedienol, which is intended for treating social anxiety disorder [5]. - Positive assertions about fasedienol's trial success were made while concealing material adverse facts about the Phase 3 PALISADE-3 trial, leading to investor damages when the truth was revealed [6].